Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up

2009 ◽  
Vol 18 (4) ◽  
pp. 449-460 ◽  
Author(s):  
Philipp Stockmann ◽  
Eleftherios Vairaktaris ◽  
Falk Wehrhan ◽  
Martin Seiss ◽  
Stephan Schwarz ◽  
...  
2005 ◽  
Vol 94 (4) ◽  
pp. 403 ◽  
Author(s):  
N.H. Creugers ◽  
A.G. Mentink ◽  
W.A. Fokkinga ◽  
C.M. Kreulen

2013 ◽  
Vol 2013 ◽  
pp. 1-10 ◽  
Author(s):  
Kostas Kalokasidis ◽  
Meltem Onder ◽  
Myrto-Georgia Trakatelli ◽  
Bertrand Richert ◽  
Klaus Fritz

In this prospective clinical study, the Q-Switched Nd:YAG 1064 nm/532 nm laser (Light Age, Inc., Somerset, NJ, USA) was used on 131 onychomycosis subjects (94 females, 37 males; ages 18 to 68 years). Mycotic cultures were taken and fungus types were detected. The laser protocol included two sessions with a one-month interval. Treatment duration was approximately 15 minutes per session and patients were observed over a 3-month time period. Laser fluencies of 14 J/cm2were applied at 9 billionths of a second pulse duration and at 5 Hz frequency. Follow-up was performed at 3 months with mycological cultures. Before and after digital photographs were taken. Adverse effects were recorded and all participants completed “self-evaluation questionnaires” rating their level of satisfaction. All subjects were well satisfied with the treatments, there were no noticeable side effects, and no significant differences were found treating men versus women. At the 3-month follow-up 95.42% of the patients were laboratory mycologically cured of fungal infection. This clinical study demonstrates that fungal nail infections can be effectively and safely treated with Q-Switched Nd:YAG 1064 nm/532 nm laser. It can also be combined with systemic oral antifungals providing more limited treatment time.


2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Kai-Hendrik Bormann ◽  
Nils-Claudius Gellrich ◽  
Heinz Kniha ◽  
Sabine Schild ◽  
Dieter Weingart ◽  
...  

Author(s):  
Ellen Pick ◽  
Nicolas Leuenberger ◽  
Irina Kuster ◽  
Nicole Selina Stutzmann ◽  
Bernd Stadlinger ◽  
...  

Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) is a dreaded complication in patients with compromised bone metabolism. The purpose of the present study was to examine the occurrence of ARONJ and its related factors among patients with a history of antiresorptive therapy undergoing tooth extraction using preventive protocols at a Swiss university clinic. Data were retrospectively pooled from health records of patients having received a surgical tooth extraction between January 2015 and April 2020 in the Clinic of Cranio-Maxillofacial and Oral surgery, University of Zurich. A total of 970 patients received an extraction with flap elevation or wound closure during this period. A total of 104 patients could be included in the study. Furthermore, variables including age, gender, smoking, risk profile, choice, indication and duration of antiresorptive therapy, number of extractions, extraction site, surgical technique, choice and duration of antibiotics as well as the presence of postoperative inflammatory complications were assessed. Overall, 4 patients developed ARONJ (incidence of 3.8%) after tooth extraction at the same location, without previous signs of osteonecrosis. Preventive methods included predominantly primary wound closure using a full thickness mucoperiosteal flap and prolonged perioperative antibiotic prophylaxis. In accordance with current literature, the applied protocol showed a reliable outcome in preventing ARONJ when a tooth extraction is required.


2016 ◽  
Vol 21 (1) ◽  
pp. 127-134 ◽  
Author(s):  
Akihiko Matsumoto ◽  
Masanori Sasaki ◽  
Rainer Schmelzeisen ◽  
Yukiko Oyama ◽  
Yoshihide Mori ◽  
...  

2018 ◽  
Vol 20 (4) ◽  
pp. 515-521 ◽  
Author(s):  
Simon Windael ◽  
Stijn Vervaeke ◽  
Lieve Wijnen ◽  
Wolfgang Jacquet ◽  
Hugo De Bruyn ◽  
...  

1975 ◽  
Vol 03 (03) ◽  
pp. 271-274 ◽  
Author(s):  
Jaakko Laitinen

The purpose of this study was to clarify the efficacy of acupuncture in the prophylaxis of migraine. 39 patients were treated by acupuncture given 5 times at weekly intervals. 92% of patients improved with acpuncture initially. Six months later 54% had relapsed to their pre-acupuncture state. The present study does not exclude the possiblity that the results were due to suggestion.


Sign in / Sign up

Export Citation Format

Share Document